August 4, 2021

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Commissioners:

We have read the statements made by Ibere Pharmaceuticals under Item 4.01 of its Form 8-K dated August 4, 2021. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Ibere Pharmaceuticals contained therein.

Very truly yours,

/s/ Marcum LLP

Marcum LLP

Attachments

  • Original document
  • Permalink

Disclaimer

Ibere Pharmaceuticals published this content on 04 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2021 18:16:12 UTC.